TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer

Cancer Epidemiology

Volumn 37, Issue 1, 2013, Pages 71-78

  Liu, Lei ^a   Zhao, Enhong ^a   Li, Chunhui ^a   Huang, Liang ^a   Xiao, Lijun ^a   Cheng, Luyang ^a   Huang, Xu ^a   Song, Youxin ^a   Xu, Dawei ^a  

^a CHENGDE MEDICAL COLLEGE   (China)

Author keywords

Marker; Metastasis; NSCLC; RNA interference; Survival; TRIM28

Indexed keywords

CYTOKERATIN 19; PROTEIN; TRIPARTITE MOTIF 28 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DNA CONTENT; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; REPRESSOR PROTEINS; SURVIVAL ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84872152304     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.08.005     Document Type: Article

References (26)

1. Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer statistics, 2000. CA Cancer J Clin 2000, 50(1):7-33.
2. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
3. Matsunaga H., Hangai N., Aso Y., Okano K., Kawamura M., Kobayashi K., et al. Application of differential display to identify genes for lung cancer detection in peripheral blood. Int J Cancer 2002, 156:592-599.
4. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011, 11:792-804.
5. Yokoe T., Toiyama Y., Okugawa Y., Tanaka K., Ohi M., Inoue Y., et al. KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol 2010, 17:821-828.
6. Noguchi K., Okumura F., Takahashi N., Kataoka A., Kamiyama T., Todo S., et al. TRIM40 promotes neddylation of IKK and is downregulated in gastrointestinal cancers. Carcinogenesis 2011, 32:995-1004.
7. Zhou Z.Y., Yang G.Y., Zhou J., Yu M.H. Significance of TRIM29 and β-catenin expression in non-small-cell lung cancer. J Chin Med Assoc 2012, 75(6):269-274.
8. Liu J., Welm B., Boucher K.M., Ebbert M.T., Bernard P.S. TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer. Am J Pathol 2012, 180(2):839-847.
9. Ryu Y.S., Lee Y., Lee K.W., Hwang C.Y., Maeng J.-S., Kim J.-H., et al. TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP). J Biol Chem 2011, 286:25729-25738.
10. Endo H., Ikeda K., Urano T., Horie-Inoue K., Inoue S. Terf/TRIM17 stimulates degradation of kinetochore protein ZWINT and regulates cell proliferation. J Biochem 2012, 151:139-144.
11. Sugiura T. The cellular level of TRIM31, an RBCC protein overexpressed in gastric cancer, is regulated by multiple mechanisms including the ubiquitin-proteasome system. Cell Biol Int 2011, 35(7):657-661.
12. Ryan R.F., Schultz D.C., Ayyanathan K., Singh P.B., Friedman J.R., Fredericks W.J., et al. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol Cell Biol 1999, 19:4366-4378.
13. Lechner M.S., Begg G.E., Speicher D.W., Rauscher F.J. Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential. Mol Cell Biol 2000, 20:6449-6465.
14. Ziv Y., Bielopolski D., Galanty Y., Lukas C., Taya Y., Schultz D.C., et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat Cell Biol 2006, 8:870-876.
15. Wang C., Ivanov A., Chen L., Fredericks W.J., Seto E., Rauscher 3rd F.J., et al. MDM2 interaction with nuclear corepressor KAP1 contributes to P53 inactivation. EMBO J 2005, 24:3279-3290.
16. Venkov C.D., Link A.J., Jennings J.L., Plieth D., Inoue T., Nagai K., et al. A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest 2007, 117:482-491.
17. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition; new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981.
18. Guarino M., Rubino B., Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-318.
19. Moustakas A., Heldin C.H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007, 98:1512-1520.
20. Lee Y.K., Thomas S.N., Yang A.J., Ann D.K. Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J Biol Chem 2007, 0282:1595-1606.
21. Okamoto K., Kitabayashi I., Taya Y. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. Biochem Biophys Res Commun 2006, 351:216-222.
22. Iwao K., Watanabe T., Fujiwara Y., Takami K., Kodama K., Higashiyama M., et al. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small cell lung cancer. Int J Cancer 2001, 91:433-437.
23. Mitas M., Hoover L., Silvestri G., Reed C., Green M., Turrisi A.T., et al. LUNX is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood. J Mol Diagn 2003, 5:237-242.
24. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572.
25. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-458.
26. Gupta G.P., Massague J. Cancer metastasis: building and framework. Cell 2006, 127:679-695.